Matteo Bauckneht/LinkedIn
Aug 18, 2025, 19:17
Matteo Bauckneht: Pitfalls in PSMA-Based RLT – A Case-Based Review at EANM25
Matteo Bauckneht, Associate Professor of Nuclear Medicine at the University of Genoa, shared a post on LinkedIn:
“PSMA-based radioligand therapy is a promising option in the management of metastatic castration-resistant prostate cancer, yet several pitfalls remain in clinical practice.
At EANM25, the session ‘Pitfalls in PSMA-based RLT: case-based review’ will address the most frequent challenges, focusing on practical insights to refine strategies, avoid common errors, and improve patient care.
- LIPS 9 – Oncology and Theranostics Committee
- Tuesday, October 7 | 08:00–09:30
- Save the date – we look forward to seeing you in Barcelona!”
You can find more posts about Prostate Cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 18, 2025, 18:55
Aug 18, 2025, 17:21
Aug 18, 2025, 17:13
Aug 18, 2025, 17:04